TB

Tomer Berkovitz

Managing Partner at aMoon Fund

Boston, Massachusetts

Overview 

Tomer Berkovitz is a Managing Partner at aMoon Fund in Boston, Massachusetts, with a background in corporate finance and investment banking. He has served on the boards of companies like SOPHiA GENETICS and PrognomiQ, and has made significant investments in successful companies such as Omada Health and Seer. Highlights of Tomer's career include his role as COO & CFO at Alcobra and his experience at JPMorgan as an Executive Director in Investment Banking.

Work Experience 

  • Managing Partner

    2023 - Current

  • General Partner

    2018 - 2023

    aMoon is a global HealthTech & Life Sciences Investment Manager with >$1.3B AUM. Our investment platform includes three funds: early-stage (Velocity), late-stage (Growth) and public equity (Edge).

  • Board Member

    2020

    NASDAQ: SOPH

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Raised $265,152,150.00 from Perceptive Advisors.

  • Board Member

    2024

  • Board Member

    2020

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

Raised $135,000,000.00 from Invus, aMoon Fund, Catalio Capital Management, Seer and Bruker.

  • Board Member

    2023

Connie Health empowers older Americans to make confident, worry-free healthcare decisions.

Raised $16,000,000.00 from Abstract, Zach Weinberg, Nat Turner, Khosla Ventures, Dynamic Loop Capital, Arkitekt Ventures, Pitango VC and Assaf Wand.

  • Board Observer

    2021

Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.

Raised $528,520,000.00 from Trousdale Ventures, Wellington Management, Empede Capital, aMoon Fund, Civilization Ventures, Fidelity, Perceptive Advisors and Revelation Partners.

  • Board Member

    2018 - 2021

    Acquired by Nanox (NASDAQ: NNOX)

  • Board Observer

    2019 - 2020

    NASDAQ: SEER

Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.

Raised $169,500,000.00 from Fidelity, Maverick Ventures, aMoon Fund, HBM Healthcare Investments, Solasta Ventures, Emerson Collective, T. Rowe Price, Invus, Invus and Maverick Ventures.

  • COO & CFO

    2014 - 2018

    NASDAQ-traded biopharmaceutical company, merged with Arcturus Therapeutics (NASDAQ: ARCT)

  • Executive Director, Investment Banking

    2012 - 2014

  • Vice President, Investment Banking

    2010 - 2011

  • Associate, Investment Banking

    2008 - 2009

J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .

Articles About Tomer

Relevant Websites